Comont, Thibault
Nicolau-Travers, Marie-Laure
Bertoli, Sarah
Recher, Christian
Vergez, Francois
Treiner, Emmanuel http://orcid.org/0000-0001-6249-4534
Funding for this research was provided by:
Ligue Contre le Cancer
Article History
Received: 12 February 2021
Accepted: 16 August 2021
First Online: 3 September 2021
Declarations
:
: T.C received honoraria and/or research or educational support from AbbVie, AstraZeneca, Bristol Myers Squibb (Celgene), Novartis and Takeda. S.B. has served on advisory boards for Daiichi-Sankyo, Astellas, Sanofi, and Jazz Pharmaceuticals. CR received research grants (my institution) by Abbvie, Amgen, Novartis, Celgene, Jazz Pharma, Agios, Daiichi-Sankyo, Astellas, Roche, MaatPharma; and has served on advisory boards for Abbvie, Janssen, Jazz Pharma, Daiichi-Sankyo, Astellas, Novartis, Celgene, Takeda, Roche, Otsuka, Macrogenics, Pfizer. F.V received research support from Pierre-Fabre. Other authors declare that they have no conflict of interest.
: Blood samples from healthy donors were obtained through a convention between the Etablissement Français du Sang (EFS)—Midi-Pyrénées and the University Hospital of Toulouse. Patients with AML gave their written consent to participate in the study.